These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3444478)

  • 21. Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.
    Bryan-Lluka LJ; Seers H; Sharpe I
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):536-44. PubMed ID: 8740147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release of noradrenaline from isolated rat tail artery induced by bafilomycin A1.
    Palatý V
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):431-7. PubMed ID: 8935710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of monoamine oxidase activity on the release of noradrenaline by tyramine.
    Brandão F; Araújo D; Monteriro JG
    J Pharm Pharmacol; 1989 Oct; 41(10):729-32. PubMed ID: 2575157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of the release of 3H-noradrenaline by dimethylphenylpiperazinium (DMPP) in the rat vas deferens.
    Niebler M; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):43-9. PubMed ID: 2314482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences between the neuronal handling of 3H-7- and 3H-7,8-(-)noradrenaline: implications for the release of the labelled neurotransmitter by nerve stimulation.
    Henseling M
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):129-35. PubMed ID: 2882429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium-dependence of the saturability of carrier-mediated noradrenaline efflux from noradrenergic neurones in the rat vas deferens.
    Bönisch H; Fuchs G; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):131-4. PubMed ID: 3703019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early intraneuronal mobilization and deamination of noradrenaline during global ischemia in the isolated perfused rat heart.
    Carlsson L; Graefe KH; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):508-18. PubMed ID: 3437922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential distribution in, and release from, sympathetic nerve endings of endogenous noradrenaline and recently incorporated catecholamines.
    Moura D; Azevedo I; Guimarães S
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):153-9. PubMed ID: 2234100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prejunctional actions of tacrine on autonomic neuroeffector transmission in rabbit isolated pulmonary artery and rat isolated atria.
    Fabiani ME; Kabo P; Story DF
    Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):631-43. PubMed ID: 1395107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoradiographic study of the rat vas deferens incubated with 3H-noradrenaline.
    Azevedo I; Moura D; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):245-8. PubMed ID: 2234107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a reserpine-like agent on the release and metabolism of [3H]NA in cell bodies and terminals.
    Filinger EJ
    Gen Pharmacol; 1994 Sep; 25(5):1039-43. PubMed ID: 7835622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart.
    Haass M; Hock M; Richardt G; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):509-15. PubMed ID: 2615846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of beta-phenylethylamine and d-amphetamine on rat isolated atria.
    Pesce G; Adler-Graschinsky E
    J Pharmacol Exp Ther; 1983 Oct; 227(1):205-14. PubMed ID: 6555238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of partial inhibition of monoamine oxidase on the steady-state rate of deamination of 3H-catecholamines in two metabolizing systems.
    Cassis L; Ludwig J; Grohmann M; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):253-61. PubMed ID: 3762740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deamination of hordenine by monoamine oxidase and its action on vasa deferentia of the rat.
    Barwell CJ; Basma AN; Lafi MA; Leake LD
    J Pharm Pharmacol; 1989 Jun; 41(6):421-3. PubMed ID: 2570842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
    Zeitner CJ; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):397-402. PubMed ID: 3821932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The functional coupling of neuronal and extraneuronal transport with intracellular monoamine oxidase.
    Trendelenburg U; Cassis L; Grohmann M; Langeloh A
    J Neural Transm Suppl; 1987; 23():91-101. PubMed ID: 3295118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue.
    Kurz T; Richardt G; Seyfarth M; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):7-16. PubMed ID: 8832582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanism of [3H]noradrenaline release by histamine and its analogs from the rat vas deferens.
    Boudreau NJ; Vohra MM
    Can J Physiol Pharmacol; 1991 Apr; 69(4):469-74. PubMed ID: 2059909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of sympathomimetic agents on noradrenaline efflux from a blood vessel.
    Frost BR; Frewin DB; Downey JA
    Eur J Pharmacol; 1980 Oct; 67(1):85-9. PubMed ID: 7418734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.